Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 3,800 | $4.44 | $16,870.10 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 10 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,154,153 F1 · price: This is a weighted average price. Read SEC document |
| April 20, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 3,500 | $3.90 | $13,647.20 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 9 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,150,353 F1 · price: This is a weighted average price. Read SEC document |
| April 19, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 5,801 | $3.64 | $21,109.84 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 8 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,146,853 F1 · price: This is a weighted average price. Read SEC document |
| April 16, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 9,001 | $3.83 | $34,463.03 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 7 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnership Disclosed balance after: 1,141,052 F1 · price: This is a weighted average price. Read SEC document |
| April 15, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 322 | $3.85 | $1,239.18 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 6 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,132,051 F1 · price: This is a weighted average price. Read SEC document |
| April 14, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 17,152 | $3.95 | $67,704.09 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 5 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,131,729 F1 · price: This is a weighted average price. Read SEC document |
| April 13, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 5,800 | $3.97 | $23,039.92 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 4 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,114,577 F1 · price: This is a weighted average price. Read SEC document |
| April 12, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 13,146 | $4.00 | $52,587.94 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 3 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,108,777 F1 · price: This is a weighted average price. Read SEC document |
| April 09, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 27,811 | $4.08 | $113,471.66 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 2 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,095,631 F1 · price: This is a weighted average price. Read SEC document |
| April 08, 2021 Filed May 11, 2021 21:04 UTC |
AWM Investment Company, Inc.10% owner
|
PurchaseCommon Stock | 15,000 | $4.08 | $61,257.00 |
DisclosureSEC source: 0001535264-21-000032 · primary_doc.xml · nonDerivative · entry 1 AWM Investment Company, Inc. · CIK 0001535264 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Partnerships Disclosed balance after: 1,067,820 F1 · price: This is a weighted average price. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:11 UTC |
Szot Matthew KDirector
|
GrantStock Option · Derivative | 16,202 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000024 · ownership.xml · derivative · entry 2 Szot Matthew K · CIK 0001401385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,202 Underlying: Common Stock · 16,202 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:11 UTC |
Szot Matthew KDirector
|
GrantRestricted Stock | 12,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000024 · ownership.xml · nonDerivative · entry 1 Szot Matthew K · CIK 0001401385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,451 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:09 UTC |
Shum SteveDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 180,000 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000022 · ownership.xml · derivative · entry 1 Shum Steve · CIK 0001578898 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2030-12-31 F1 · derivative.exercise_date: The option vests in equal monthly increments over a period of three years from the grant date. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:05 UTC |
Ryan BarbaraDirector
|
GrantStock Option · Derivative | 13,574 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000018 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,574 Underlying: Common Stock · 13,574 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:05 UTC |
Ryan BarbaraDirector
|
GrantRestricted Stock | 10,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000018 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:08 UTC |
Segal JeffreyDirector
|
GrantStock Option · Derivative | 11,823 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000020 · ownership.xml · derivative · entry 2 Segal Jeffrey · CIK 0001832552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,823 Underlying: Common Stock · 11,823 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:08 UTC |
Segal JeffreyDirector
|
GrantRestricted Stock | 8,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000020 · ownership.xml · nonDerivative · entry 1 Segal Jeffrey · CIK 0001832552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,975 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:02 UTC |
DAVIS TRENT DDirector
|
GrantStock Option · Derivative | 14,012 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000014 · ownership.xml · derivative · entry 2 DAVIS TRENT D · CIK 0001217815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,012 Underlying: Common Stock · 14,012 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:02 UTC |
DAVIS TRENT DDirector
|
GrantRestricted Stock | 10,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000014 · ownership.xml · nonDerivative · entry 1 DAVIS TRENT D · CIK 0001217815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,573 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:04 UTC |
Doody KevinDirector · Medical Director
|
GrantStock Option · Derivative | 10,947 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000016 · ownership.xml · derivative · entry 2 Doody Kevin · CIK 0001744246 · Director · Medical Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,947 Underlying: Common Stock · 10,947 shares Expires 2030-12-31 F1 · derivative.exercise_date: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:04 UTC |
Doody KevinDirector · Medical Director
|
GrantRestricted Stock | 8,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-21-000016 · ownership.xml · nonDerivative · entry 1 Doody Kevin · CIK 0001744246 · Director · Medical Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,821 F1 · security: The restricted stock and the option vest in monthly increments over a period of twelve months from the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:01 UTC |
Campbell Michael Jos.Director · Chief Operating Officer
|
GrantStock Option · Derivative | 165,000 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001185185-21-000012 · ownership.xml · derivative · entry 1 Campbell Michael Jos. · CIK 0001722347 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2030-12-31 F1 · derivative.exercise_date: The option vests in equal monthly increments over a period of three years from the grant date. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:32 UTC |
Szot Matthew KDirector
|
GrantStock Option · Derivative | 2,339 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001185185-20-001695 · ownership.xml · derivative · entry 2 Szot Matthew K · CIK 0001401385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,339 Underlying: Common Stock · 2,339 shares Expires 2025-11-27 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:32 UTC |
Szot Matthew KDirector
|
GrantCommon Stock | 2,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-001695 · ownership.xml · nonDerivative · entry 1 Szot Matthew K · CIK 0001401385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,339 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC |
Segal JeffreyDirector
|
GrantStock Option · Derivative | 1,137 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001185185-20-001694 · ownership.xml · derivative · entry 2 Segal Jeffrey · CIK 0001832552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137 Underlying: Common Stock · 1,137 shares Expires 2025-11-27 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC |
Segal JeffreyDirector
|
GrantCommon Stock | 1,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-001694 · ownership.xml · nonDerivative · entry 1 Segal Jeffrey · CIK 0001832552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC |
Ryan BarbaraDirector
|
GrantStock Option · Derivative | 2,317 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001185185-20-001693 · ownership.xml · derivative · entry 2 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Underlying: Common Stock · 2,317 shares Expires 2025-11-27 Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 22:30 UTC |
Ryan BarbaraDirector
|
GrantCommon Stock | 2,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-001693 · ownership.xml · nonDerivative · entry 1 Ryan Barbara · CIK 0001827169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:12 UTC |
Karloff Kathleen tDirector
|
GrantStock Option · Derivative | 99,112 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001185185-20-000146 · ownership.xml · derivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F1 · derivative.exercise_date: 20% of the option vests upon grant and the remainder vests in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 02:11 UTC |
Shum SteveDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 99,112 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001185185-20-000144 · ownership.xml · derivative · entry 1 Shum Steve · CIK 0001578898 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F1 · derivative.exercise_date: 20% of the option vests upon grant and the remainder vests in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 02:08 UTC |
Doody KevinDirector · Medical Director
|
GrantRestricted Stock Units · Derivative | 99,112 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-000142 · ownership.xml · derivative · entry 2 Doody Kevin · CIK 0001744246 · Director · Medical Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F2 · derivative.exercise_date: Represents a grant of restricted stock units of the Issuer. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Issuer common stock. 20% of the units vest upon grant and the remainder vest in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 02:08 UTC |
Doody KevinDirector · Medical Director
|
GrantStock Option · Derivative | 99,112 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001185185-20-000142 · ownership.xml · derivative · entry 1 Doody Kevin · CIK 0001744246 · Director · Medical Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F1 · derivative.exercise_date: 20% of the option vests upon grant and the remainder vests in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 02:02 UTC |
Campbell Michael Jos.Director · Chief Operating Officer
|
GrantStock Option · Derivative | 99,112 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001185185-20-000140 · ownership.xml · derivative · entry 1 Campbell Michael Jos. · CIK 0001722347 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F1 · derivative.exercise_date: 20% of the option vests upon grant and the remainder vests in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 01:57 UTC |
DAVIS TRENT DDirector
|
GrantRestricted Stock Units · Derivative | 99,112 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-000138 · ownership.xml · derivative · entry 2 DAVIS TRENT D · CIK 0001217815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F2 · derivative.exercise_date: Represents a grant of restricted stock units of the Issuer. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Issuer common stock. 20% of the units vest upon grant and the remainder vest in monthly increments over a period of ten months from the date of grant. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 01:57 UTC |
DAVIS TRENT DDirector
|
GrantStock Option · Derivative | 99,112 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001185185-20-000138 · ownership.xml · derivative · entry 1 DAVIS TRENT D · CIK 0001217815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,112 Underlying: Common Stock · 99,112 shares Expires 2030-02-05 F1 · derivative.exercise_date: 20% of the option vests upon grant and the remainder vests in monthly increments over a period of ten months from the date of grant. Read SEC document |
| January 17, 2020 Filed Jan 22, 2020 01:29 UTC |
Campbell Michael Jos.Director · Chief Operating Officer
|
GrantStock Option · Derivative | 4,000,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001185185-20-000062 · ownership.xml · derivative · entry 2 Campbell Michael Jos. · CIK 0001722347 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000,000 Underlying: Common Stock · 4,000,000 shares Expires 2030-01-17 F1 · derivative.exercise_date: 25% of the option vests upon grant, with the remainder vesting in monthly increments over a period of two years from the date of grant. Read SEC document |
| January 17, 2020 Filed Jan 22, 2020 01:29 UTC |
Campbell Michael Jos.Director · Chief Operating Officer
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-20-000062 · ownership.xml · nonDerivative · entry 1 Campbell Michael Jos. · CIK 0001722347 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,607,800 Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 19:30 UTC |
Bowdring Robert Joseph JrDirector
|
OtherStock Option · Derivative | 875,050 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001185185-19-001482 · ownership.xml · derivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875,050 Underlying: Common Stock · 875,050 shares Expires 2029-10-29 F1 · security: The option was granted in consideration of the Reporting Person's waiver of rights to certain accrued and unpaid salary amounts. F2 · derivative.exercise_date: The option vests upon the earlier of (i) the Issuer generating $1.5 million in revenue in fiscal 2020 or 2021 or (ii) the Issuer raising at least $2.5 million in an equity financing. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 19:28 UTC |
Karloff Kathleen tDirector
|
OtherStock Option · Derivative | 962,336 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001185185-19-001480 · ownership.xml · derivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962,336 Underlying: Common Stock · 962,336 shares Expires 2029-10-29 F1 · security: The option was granted in consideration of the Reporting Person's waiver of rights to certain accrued and unpaid salary amounts. F2 · derivative.exercise_date: The option vests upon the earlier of (i) the Issuer generating $1.5 million in revenue in fiscal 2020 or 2021 or (ii) the Issuer raising at least $2.5 million in an equity financing. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 23:23 UTC |
Shum SteveDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 6,483,171 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001185185-19-001411 · ownership.xml · derivative · entry 2 Shum Steve · CIK 0001578898 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,483,171 Underlying: Common Stock · 6,483,171 shares Expires 2029-10-16 F2 · derivative.exercise_date: The option vests in equal monthly increments over a period of three years from the grant date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 23:23 UTC |
Shum SteveDirector · Chief Executive Officer
|
GrantRestricted Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-19-001411 · ownership.xml · nonDerivative · entry 1 Shum Steve · CIK 0001578898 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: The restricted stock vests in equal monthly increments over a period of one year from the grant date. Read SEC document |
| December 03, 2018 Filed Dec 3, 2018 12:58 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience common stock | 500,000 | $0.05 | $25,000.00 |
DisclosureSEC source: 0001479791-18-000020 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,694,000 Read SEC document |
| December 03, 2018 Filed Dec 3, 2018 12:58 UTC |
Ranoux Claude10% owner
|
OtherINVO Bioscience common stock | 1,000,000 | $0.00 | $100.00 |
DisclosureSEC source: 0001479791-18-000020 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194,000 Read SEC document |
| December 03, 2018 Filed Feb 1, 2019 18:35 UTC |
Ranoux Claude10% owner
|
SaleINVO BIOSCIENCE Common Stock | 500,000 | $0.05 | $25,000.00 |
DisclosureSEC source: 0001479791-19-000002 · primary_doc.xml · nonDerivative · entry 11 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,694,000 Read SEC document |
| December 03, 2018 Filed Feb 1, 2019 18:35 UTC |
Ranoux Claude10% owner
|
OtherINVO BIOSCIENCE Common Stock | 1,000,000 | $0.00 | $100.00 |
DisclosureSEC source: 0001479791-19-000002 · primary_doc.xml · nonDerivative · entry 10 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194,000 Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 13:26 UTC |
Ranoux Claude10% owner
|
Grantrestricted common shares of INVO Bioscience | 910,878 | $0.39 | $355,242.42 |
DisclosureSEC source: 0001479791-18-000019 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,194,000 Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 17:13 UTC |
Bowdring Robert Joseph JrDirector
|
GrantCommon Stock | 1,015,942 | $0.39 | $396,217.38 |
DisclosureSEC source: 0001185185-18-001909 · ownership.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,715,942 Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 17:19 UTC |
Karloff Kathleen tDirector · Chairwoman and CEO
|
GrantCommon Stock | 1,040,183 | $0.39 | $405,671.37 |
DisclosureSEC source: 0001185185-18-001913 · ownership.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · Chairwoman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200,183 Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:22 UTC |
Shum SteveDirector
|
GrantCommon Stock | 400,000 | $0.39 | $156,000.00 |
DisclosureSEC source: 0001185185-18-001915 · ownership.xml · nonDerivative · entry 1 Shum Steve · CIK 0001578898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:16 UTC |
Campbell Michael Jos.Director
|
GrantCommon Stock | 400,000 | $0.39 | $156,000.00 |
DisclosureSEC source: 0001185185-18-001911 · ownership.xml · nonDerivative · entry 1 Campbell Michael Jos. · CIK 0001722347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,800 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.